PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.

• Rimmel Yosra Kanoun,
• Nour Ben Adejlil,
• Jaied Rabeb,
• Roua Hsasna,
• Frigui Siwar,
• Sabrine Mekni,
• Lamia Torjemane,
• Ines Turki,
• Dorra Belloumi,
• Ouerghi Rihab,
• Insaf Ben Yaiche,
• Achour Wafa,
• Ladeb Saloua,
• Tarek Ben Othman

Affiliations

Rimmel Yosra Kanoun

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Nour Ben Adejlil

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Jaied Rabeb

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Roua Hsasna

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Frigui Siwar

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Sabrine Mekni

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Lamia Torjemane

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Ines Turki

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Dorra Belloumi

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Ouerghi Rihab

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Insaf Ben Yaiche

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Achour Wafa

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Ladeb Saloua

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia

Tarek Ben Othman

1 National Bone Marrow Transplant Center, Hematology, Tunis, Tunisia